divend from preferred stock put <.32> eps at a loss for the year.
Here is hole report.
Breaking it down for fourth quarter:
net income: 1,174,000
Diluted shares: 14,909,313
Q3 was 0.09 with higher net income (1.4m). Q4 failed to match or beat Q3 even though the share counts used were the same for both quarters.
I could not find that earnings net income number for the 4th quarter in the 10K. $1,174,000.
Could tell us how you got that number?
The diluted shares, 14,909,313 does not include:
4,166,667 shares of series B convertible preferred stock or warrants to purchase a total of 1,000,000 shares at an exercise price of $2.40 per share, subject to adjustments.
So adding these to the total, I figure (using your number for profit in the last Q) earnings/diluted shares:
1,174,000/20M = 5.9c/share.
I don't know if anyone has followed the Chinese winter this year though it was terrible. APWR was always off a bit in the winter months as well.... To that end, not a bad Q, shouldn't fluctuate much I would look for a nice run up over the Summer when the country can function a bit better on building power infrastructure...Certainly not a Winter task.... Nice Job!
CPQQ 10K: Probably one of the strongest earnings reports I've read in a while. This company has achieved amazing results, and is on a clear path to prosperity! Tomorrow should be terrific! Wow!
As the series B Preferred Stock does not require redemption by the Company, upon issuance, the Company recorded a one-time deemed dividend and as an increase in additional paid-in capital, the intrinsic value of the beneficial conversion feature (the "BCF") of $9,045,005. The intrinsic value of the BCF is the difference between the fair value of the common stock underlying the series B Preferred Stock at issuance and the amount of proceeds to be allocated to the preferred stock. The proceeds of $5,000,000 were allocated to the preferred stock and warrants based on their relative fair values. The warrants were valued using the BSM model and recorded in additional paid-in capital.